Medidata Solutions Signs Contract Extension with Bristol-Myers Squibb

Posted on: Sun, 25 Oct 2009 22:37:00 EDT


Symbols: BMY, MDSO
Oct 26, 2009 (Close-Up Media via COMTEX) --
MDSO | Quote | Chart | News | PowerRating -- Medidata Solutions, a provider of hosted clinical development solutions, announced a multi-year contract extension with Bristol-Myers Squibb Company for use of Medidata Grants Manager, an investigator site benchmarking tool that helps sponsors ensure fair and consistent investigator payments and mitigate compliance risks.

Under this new contract, Bristol-Myers Squibb said it will also be expanding its use of Grants Manager to include analysis and contracting modules.

"Our lasting relationship with Bristol-Myers Squibb is representative of the reliability of our solutions, services and support teams, which we will continue to make every effort to deliver throughout our collaboration with the Bristol-Myers Squibb clinical team," said Tarek Sherif, Chairman and CEO, Medidata Solutions.

Medidata Solutions is a provider of hosted clinical development solutions for customers' clinical development processes.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

For full details on Bristol-Myers Squibb Co (BMY) BMY. Bristol-Myers Squibb Co (BMY) has Short Term PowerRatings at TradingMarkets. Details on Bristol-Myers Squibb Co (BMY) Short Term PowerRatings is available at This Link.

For full details on Medidata Solutions Incorporated (MDSO) MDSO. Medidata Solutions Incorporated (MDSO) has Short Term PowerRatings at TradingMarkets. Details on Medidata Solutions Incorporated (MDSO) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.